Skip to content

Analgesic Effectiveness of PENG Block in Programmed Hip Arthroplasty Surgery

Analgesic Effectiveness of PENG Block in Programmed Hip Arthroplasty Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04650100
Acronym
THAPeng
Enrollment
64
Registered
2020-12-02
Start date
2020-12-14
Completion date
2021-07-08
Last updated
2025-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Keywords

Total hip arthroplasty, PENG bloc, local anaesthetics infiltration, postoperative pain

Brief summary

The intra- and peri-articular infiltration of local anaesthetics realized at the end of total hip arthroplasty surgeries is an effective analgesic technique, but it can be insufficient to manage the possibly intense postoperative pain. Regional anaesthesia (RA) like the recently described pericapsular nerve group (PENG) block could provide additional analgesic benefit in this setting. Investigators main objective is to demonstrate the analgesic benefits (postoperative pain score and morphine consumption) of the PENG block when added to intra- and peri-articular infiltration of local anaesthetic following total hip arthroplasty. Investigators make the assumption that i) the PENG bloc could reduce the postoperative 24 first hours morphine consumption by 30%, ii) the PENG block could spare the motor function of the quadriceps and adductor muscles, and iii) the PENG bloc could be well tolerated allowing a high level of patient satisfaction.

Detailed description

A recent study has revealed a region of pericapsular terminal branches of the femoral nerve and the obturator nerve accessible to ultrasound-guided regional anaesthesia. This technique, also called the PENG block, has recently been described with a substantial benefit on pain at rest and induced by mobilization in cases series of patients undergoing hip fracture surgery. To investigators knowledge, no randomized data concerning the analgesic efficacy of the PENG block has been published in the setting of elective total hip arthroplasty. The PENG block would allow a significant analgesic contribution when added to intra- and peri-articular infiltration of local anaesthetics while being well tolerated with few undesirable effects. Moreover, the PENG block could spare the motor function of the quadriceps and adductor muscles allowing enhanced recovery after surgery

Interventions

PROCEDUREultrasound-guided PENG bloc realized before surgery

ultrasound-guided PENG block realized before surgery. The PENG block, described by Giron-Arebgi is made in the supine position. The ultrasound probe used is a 5 MHz high frequency linear probe placed parallel to the line delimited by the anterior-inferior iliac spine (lateral) and the pubis (medial). The needle used is an 80 mm, 22G, needle inserted in the ultrasound plane. The slow and fractioned injection of 20 ml of Ropivacaine 4.75 mg/ml is performed in the fascia between the psoas tendon and the iliopubic eminence under ultrasound guidance.

Sponsors

University Hospital, Toulouse
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Scheduled for total hip arthroplasty surgery under general anaesthesia * Affiliated of a social security scheme * Having signed the written informed consent

Exclusion criteria

* Total hip arthroplasty revision surgery * Refusal of the patient to participate * Existence of major spontaneous or acquired haemostasis disorders * Infection at the puncture site * Allergy to local anaesthetics * Pregnancy or breast-feeding * Patients under the protection of adults (guardianship, curatorship or protection of justice) * Patients whose cognitive state does not allow assessment by the scales used.

Design outcomes

Primary

MeasureTime frameDescription
Cumulated postoperative morphine consumption 24 hours after surgery24 hourscalcul of Cumulated postoperative morphine consumption 24 hours after surgery

Secondary

MeasureTime frameDescription
Cumulated postoperative morphine consumption 48 hours after surgeryHour 48Cumulated postoperative morphine consumption 48 hours after surgery
Evaluation of pain in the PACUHour 1Evaluation of pain using a simple numeric rating scale (NRS from 0 to 10) in the PACU
Evaluation of pain 24 hours after surgeryHour 24Evaluation of pain using a simple numeric rating scale (NRS from 0 to 10) 24 hours after surgery
Evaluation of pain 48 hours after surgeryHour 48Evaluation of pain using a simple numeric rating scale (NRS from 0 to 10) 48 hours after surgery
Evaluation of the pain potentially induced by the realization of the PENG blockHour 0Evaluation of the pain potentially induced by the realization of the PENG block with Likert scale from 1 to 5, 1 is for no pain, 5 is for the worse pain
Cumulated postoperative morphine consumption in the post anaesthesia care unit (PACU)Hour 1Cumulated postoperative morphine consumption in the post anaesthesia care unit (PACU)
Evaluation of adverse effects associated with the use of morphineHour 0Evaluation of adverse effects associated with the use of morphine
Evaluation of the patients' satisfactionHour 24Evaluation of the patients' satisfaction by the EVAN-LR score realized 24 hours after surgery. EVAN-LR is a scale assessing perioperative patient's satisfaction with Loco Regional anaesthesia
Evaluation of the adductor muscles weaknessHour 24Evaluation of the adductor muscles weakness by a thigh adduction test performed 24 hours after surgery
Evaluation of the quadricipital muscles weaknessHour 24Evaluation of the quadricipital muscles weakness by a Timed to Up and Go Test performed 24 hours after surgery
Evaluation of adverse effects associated with the PENG blockHour 0Evaluation of adverse effects associated with the PENG block

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026